Varda Space Industries has announced key leadership appointments aimed at enhancing growth within the pharmaceutical and defense sectors. Steve Layne has been appointed as Chief Revenue Officer, bringing over 30 years of experience in defense programs, including high-priority hypersonic initiatives. Aaron Huber joins as Chief Financial Officer, with nearly two decades of expertise in deep-tech and capital markets.
The company’s CEO, Will Bruey, emphasized that these appointments will bolster both commercial and financial leadership, complementing Varda’s technical advancements. With six successful launch missions under its belt, Varda is on track to deliver the first commercial pharmaceutical product produced in low Earth orbit, capitalizing on microgravity for unique drug formulations.
Headquartered in El Segundo, California, Varda is focused on creating a thriving orbital economy through microgravity-enabled pharmaceutical manufacturing.
